Delhi HC orders forensic audit into Fortis Healthcare promoter share dissipation
- Delhi High Court directs forensic audit into promoter shareholding dissipation and change in control
- Order issued on August 31, 2026, in case involving Daiichi Sankyo Company, Limited
- Court imposed no liability, penalty, or fine on Fortis Healthcare
- Company was not a party to the original dispute or execution proceedings

*this image is generated using AI for illustrative purposes only.
The Delhi High Court has directed a forensic audit into the dissipation of shareholding by Fortis Healthcare Limited’s erstwhile promoters and the subsequent change in control of the company.
Fortis Healthcare disclosed the order on September 1, 2026, noting that the court did not impose any liability, penalty, or fine on the listed entity. The investigation stems from applications filed by Daiichi Sankyo Company, Limited.
Court Order Details
A single judge bench of the Delhi High Court passed the order on August 31, 2026. The mandate requires a factual enquiry into:
- The dissipation of the shareholding of the Singh Brothers, the company’s erstwhile promoters.
- The subsequent change in control of the company.
- The role of relevant stakeholders, including banks, financial institutions, erstwhile promoters, their controlled entities, and the company.
Legal Position and Impact
Fortis Healthcare stated it was neither a party to the original dispute nor a judgment debtor in the execution proceedings. The company emphasized that the forensic audit direction is purely investigative and does not result in any determination or fastening of liability upon the entity.
The management is reviewing the judgment with legal counsels to evaluate the appropriate course of action under applicable law. The company reaffirmed its commitment to corporate governance and regulatory compliance.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.14% | -0.02% | -4.08% | -3.79% | -0.49% | 0.0% |
How might the forensic audit's findings regarding the Singh Brothers' shareholding dissipation impact Fortis Healthcare's current valuation and investor confidence?
What potential liabilities could emerge for the banks and financial institutions involved if the audit reveals irregularities in their role during the change of control?
Could this legal precedent influence how other Indian healthcare conglomerates structure their promoter exit strategies and stakeholder transitions?


































